Neurons expressing urocortin 1 (UCN1) represent a critical population in the stress response system. Urocortin 1 is a member of the corticotropin-releasing factor (CRF) family of neuropeptides, which also includes CRF, urocortin 2 (UCN2/scortin), and urocortin 3 (UCN3/stresscopin). UCN1 binds to both CRF receptor 1 (CRF-R1) and CRF receptor 2 (CRF-R2), with higher affinity for CRF-R2.
¶ Gene and Peptide
| Property |
Value |
| Gene Symbol |
UCN |
| Chromosomal Location |
2p23.3 |
| Protein Name |
Urocortin |
| UniProt ID |
Q9UBB4 |
| Peptide Length |
40 amino acids |
| Family |
CRF/Cortistatin/UCN |
The UCN gene encodes prepro-urocortin, which is cleaved to produce the mature 40-amino acid peptide. UCN1 shares approximately 45% sequence homology with CRF.
Urocortin 1 has the typical structure of CRF family peptides:
- Signal peptide: N-terminal secretion signal
- Mature peptide: 40 amino acids with N-terminal活性 domain
- C-terminal extension: Important for receptor binding selectivity
- Disulfide bond: Cys-Cys bridge for structural stability
| Receptor |
Affinity (nM) |
Signaling |
| CRF-R1 |
~2-5 |
Gs (cAMP increase) |
| CRF-R2 |
~0.5-2 |
Gi (cAMP inhibition) |
UCN1 neurons are found in several key brain regions:
- Edinger-Westphal nucleus: Major site of UCN1 expression in primates
- Cerebral cortex: Layer 6 pyramidal neurons
- Hypothalamus: Paraventricular nucleus, supraoptic nucleus
- Amygdala: Central and medial nuclei
- Hippocampus: CA1-CA3 regions
- Bed nucleus of the stria terminalis (BNST): Extended amygdala
- Midbrain: Dorsal raphe, locus coeruleus
UCN1 is a key mediator of stress responses:
- HPA axis activation: Stimulates ACTH and cortisol release
- Stress adaptation: CRF-R2 signaling buffers stress responses
- Behavioral stress responses: Anxiety, fear, and avoidance
- Autonomic stress responses: Cardiovascular and metabolic effects
¶ Anxiety and Mood
- Anxiogenic effects: Via CRF-R1 activation
- Anxiolytic buffering: Via CRF-R2 activation
- Bidirectional modulation of anxiety-like behavior
- Mood regulation: Depression-related changes
- Anorexigenic signaling: Suppresses food intake
- Energy expenditure: Increases metabolic rate
- Body weight regulation: Long-term energy balance
- GI motility: Modulates gut function
- Vasodilatory effects: Via CRF-R2 in vasculature
- Cardioprotection: Protective effects in heart
- Blood pressure regulation: Central and peripheral mechanisms
- Arousal modulation: Influences wakefulness
- REM sleep: Regulation of REM sleep states
- Circadian integration: Links stress to circadian rhythms
Involvement:
- UCN1 expression altered in AD brain
- Relationship to HPA axis hyperactivity in AD
- Stress-diathesis model of AD
- Potential for CRF-based therapeutics
Mechanisms:
- Cortisol neurotoxicity
- Amyloid-beta interactions
- Tau pathology modulation
Involvement:
- Altered UCN1 in PD brain
- Stress and PD progression
- Non-motor symptoms (depression, anxiety)
- CRF-R2 neuroprotection
Involvement:
- Elevated UCN1 in depression
- Relationship to treatment resistance
- HPA axis dysregulation
- Biomarker potential
Evidence:
- Increased UCN1 in CSF of depressed patients
- UCN1 correlates with symptom severity
- Antidepressant effects of CRF-R2 activation
Involvement:
- CRF-R1 in anxiety pathogenesis
- CRF-R2 as therapeutic target
- UCN1 polymorphisms and anxiety risk
- Stress-induced anxiety
Involvement:
- Altered UCN1 in HD
- HPA axis dysfunction
- Mood and behavioral symptoms
- Stress vulnerability
UCN1 activates multiple signaling cascades:
- cAMP/PKA: Via CRF-R1 (Gs protein)
- MAPK pathway: ERK1/2 activation
- PI3K/Akt: Cell survival signaling
- PLC/IP3: Calcium mobilization (via CRF-R1)
- CRF: Functional redundancy and antagonism
- UCN2/UCN3:协同 and distinct functions
- Urocortin binding protein (UCNBP): Scavenger function
-
CRF-R1 antagonists:
- Pexacerfont, verucerfont (clinical trials)
- Anxiolytic and antidepressant potential
-
CRF-R2 agonists:
- UCN2/UCN3 analogs
- Stress resilience
-
UCN1 analogs:
- Brain-penetrant peptides
- Selective CRF-R2 modulators
- Anxiety disorders: CRF-R1 antagonists
- Depression: CRF-R modulators
- Stress-related disorders: UCN-based therapies
- Metabolic disorders: Appetite suppression
- CSF UCN1 as stress biomarker
- Blood UCN1 in psychiatric disease
- Circuit mapping: Defining UCN1 neuron connectivity
- Optogenetics: Manipulating UCN1 circuits
- Single-cell studies: Heterogeneity of UCN1 neurons
- Translational studies: UCN1 in human disease
- Urocortin in brain function (2019)
- CRF receptors in psychiatric disorders (2020)
- Urocortin and stress response (2018)
- CRF-R2 in neuroprotection (2021)
- Urocortin in depression (2019)
- HPA axis in Alzheimer's disease (2020)
- CRF family peptides in brain (2017)
- Stress and neurodegeneration (2018)